Heidi Ko: Interesting Presentation During Metastatic Breast Cancer Session at ASCO 2025
May 31, 2025, 06:31

Heidi Ko: Interesting Presentation During Metastatic Breast Cancer Session at ASCO 2025

Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:

“Interesting presentation during Metastatic Breast Cancer session on how AI-assisted support led to increased accuracy and pathologist’s concordance in interpretation of HER2 IHC score, particularly in cases of HER2-low and ultralow cases.”

Metastatic Breast Cancer

More posts featuring ASCO25.